SCHEMBL3451869

SCHEMBL3451869

c1ccc2c(c1)CCN=C2CN1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
KDM4E B2RXH2 1/20 0.60
NOS3 P29474 2/20 0.47
NOS2 P35228 1/20 0.47
MAOA P21397 1/20 0.40
SIGMAR1 Q99720 3/20 0.39
HTR1A P08908 1/20 0.39
PTAFR P25105 2/20 0.39
DRD2 P14416 2/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
METAP1 P53582 1/20 0.38
DRD4 P21917 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28110445 0.86 ALDH1A1 (0.56) ALDH1A1KDM4ENOS3NOS2PTAFR
SCHEMBL29361631 0.77 KDM4E (0.60) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL7509399 0.77 KDM4E (0.60) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL30952110 0.75 ALDH1A1 (1.00) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL14919523 0.75 ALDH1A1 (1.00) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL22995932 0.75 KDM4E (0.63) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL30952113 0.75 KDM4E (0.63) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL28122092 0.75 KDM4E (0.58) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL7819962 0.75 KDM4E (0.58) ALDH1A1KDM4ENOS3NOS2MAOA
SCHEMBL9815282 0.75 ALDH1A1 (0.58) ALDH1A1KDM4ENOS3NOS2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820692-B2 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2010-10-26 US disclosed
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2009-11-05 US disclosed
CN-100503571-C Tetrahydro isoquinoline derivative and its preparation process and medicine use UNIV CHINA PHARMA (CN) 2009-06-24 CN disclosed
EP-2045243-A1 TETRAHYDRO ISOQUINOLINE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF China Pharmaceutical University (CN) 2009-04-08 EP disclosed
CN-1887872-A Tetrahydro isoquinoline derivative and its prepn process and medicine use UNIV CHINA PHARMACY (CN) 2007-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof OPRK1, OPRD1, OPRL1 ALDH1A1 1231/4885KDM4E 1973/4885NOS3 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.